Loading publications…
The last 5 uploaded publications
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet, Florian Castet, Mathias Heikenwälder, Mala K. Maini, Vincenzo Mazzaferro, David J. Pinato, Eli Pikarsky, Andrew X. Zhu, Richard S. Finn (2021). Immunotherapies for hepatocellular carcinoma. Nature Reviews Clinical Oncology, 19(3), pp. 151-172, DOI: 10.1038/s41571-021-00573-2.
Article145 days agoEvidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
Philipp K. Haber, Marc Puigvehí, Florian Castet, Vennis Lourdusamy, Robert Montal, Parissa Tabrizian, Michael Buckstein, Edward Kim, Augusto Villanueva, Myron Schwartz, Josep M. Llovet (2021). Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020). Gastroenterology, 161(3), pp. 879-898, DOI: 10.1053/j.gastro.2021.06.008.
Article145 days agoInflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Carla Montironi, Florian Castet, Philipp K. Haber, Roser Pinyol, Miguel Torres‐Martín, Laura Torrens, Agavni Mesropian, Huan Wang, Marc Puigvehí, Miho Maeda, Wei Qiang Leow, Elizabeth Harrod, Patricia Taik, Jigjidsuren Chinburen, Erdenebileg Taivanbaatar, Chinbold Enkhbold, M. Solé Arqués, Michael Donovan, Swan N. Thung, Jaclyn Neely, Vincenzo Mazzaferro, Jeffrey Anderson, Sasan Roayaie, Myron Schwartz, Augusto Villanueva, Scott L. Friedman, Andrew Uzilov, Daniela Sia, Josep M. Llovet (2022). Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. Gut, 72(1), pp. 129-140, DOI: 10.1136/gutjnl-2021-325918.
Article145 days agoMolecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
Philipp K. Haber, Florian Castet, Miguel Torres‐Martín, Carmen Andreu-Oller, Marc Puigvehí, Maeda Miho, Pompilia Radu, Jean‐François Dufour, Chris Verslype, Carolin Zimpel, Jens U. Marquardt, Peter R. Galle, Arndt Vogel, Melanie Bathon, Tim Meyer, Ismaïl Labgaa, Antonia Digklia, Lewis R. Roberts, Mohamed A. Mohamed Ali, Beatriz Mínguez, Davide Citterio, Vincenzo Mazzaferro, Fabian Finkelmeier, Jörg Trojan, Burcin Özdirik, Tobias Müller, Moritz Schmelzle, Anthony Bejjani, Max W. Sung, Myron Schwartz, Richard S. Finn, Swan N. Thung, Augusto Villanueva, Daniela Sia, Josep M. Llovet (2022). Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma. Gastroenterology, 164(1), pp. 72-88.e18, DOI: 10.1053/j.gastro.2022.09.005.
Article145 days agoObjective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies
Masatoshi Kudo, Robert Montal, Richard S. Finn, Florian Castet, Kazuomi Ueshima, Naoshi Nishida, Philipp K. Haber, Youyou Hu, Yasutaka Chiba, Myron Schwartz, Tim Meyer, Riccardo Lencioni, Josep M. Llovet (2021). Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies. Clinical Cancer Research, 28(16), pp. 3443-3451, DOI: 10.1158/1078-0432.ccr-21-3135.
Article145 days ago